Back

Interaction with the audience

28 August 2018 (10:35 - 10:45)
Organised by:
Congress Presentation Part of: From ODYSSEY OUTCOMES results to clinical practice - Identifying patients who may benefit most from PCSK9 inhibition Lipids ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Andreas Michael Zeiher

Institute of Cardiovascular Regeneration, Frankfurt (Germany)

2 More presentations in this session

Presentation thumbnail
From identification of high CV risk patients to treatment with PCSK9i: learnings from ODYSSEY OUTCOMES.
Professor A. Zeiher (Frankfurt, DE)
Presentation thumbnail
A deeper dive into key ODYSSEY OUTCOMES results and their impact on patient management.
Professor G. Schwartz (Aurora, US)

Access the full session

Session thumbnail
From ODYSSEY OUTCOMES results to clinical practice - Identifying patients who may benefit most from PCSK9 inhibition

The Event

Event poster

ESC Congress 2018

28 August 2018 10:35 CET
You may be interested in
thumbnail
Congress Presentation
Imaging cellular interaction in arrhythmias to identify novel therapeutic targets – discussion.
28 August 2022
thumbnail
Congress Presentation
Charting the future: panel discussion and Q&A
29 August 2025
thumbnail
Congress Presentation
Conclusion
30 August 2025
thumbnail
Congress Presentation
Questions & answers.
4 April 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources